• Net sales: kSEK 0 (0).
• Operating profit: kSEK -1 663 (-697).
• Earnings per share: SEK -0,07 (-0,05).
• Liquidity at the end of the period: kSEK 4 961 (2 708).
Significant events after the end of the period:
• On April 18, 2019, CombiGene AB (publ) announced a public offer to the holders of shares and warrants of series TO1 in Panion Animal Health AB (publ) to tender all their shares and warrants to CombiGene. The full offer can be viewed on Panion’s and/or CombiGene’s websites. The acceptance period for the offer is expected to commence on or around 23 May